Kuala lumpur: SBC Medical Group Holdings Incorporated (Nasdaq SBC) ('SBC Medical' or the 'Company'), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced 'SBC Wellness 2.0,' a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management.

According to BERNAMA News Agency, the initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately $800 billion in 2025 and expand to approximately $2 trillion by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. This strategy represents a natural extension of SBC Medical's core business in Japan's approximately $4 billion aesthetic healthcare market. While Japan's domestic longevity market has already reached an estimated $34 billion, it remains in its early stages with no clear market leader, providing a significant opportunity for the Company to capture first-mover advantages. SBC Medical intends to use its existing clinic network and customer base in Japan to build recurring revenue streams and a differentiated, data-rich platform.